Dr Michael Flynn Consultant Profile
Dr. Flynn is a highly skilled Medical Oncology Consultant with a robust background in translational research and clinical trials. He earned his PhD in antibody drug conjugate translational development from University College London, where he honed his expertise in targeted cancer therapies. Dr. Flynn completed his specialist oncology training at the prestigious Royal Marsden Hospital.
During his time as a Phase I Clinical Research Fellow at UCLH’s Clinical Research Facility, Dr. Flynn gained extensive experience in early-phase clinical trials, serving as a sub-investigator on numerous first-in-man and later-stage development studies. He now leads as Principal Investigator on gynaecological-specific trials and plays a key role as a sub-investigator on tumour-agnostic targeted therapy, immunotherapy, and combination therapy trials. Dr. Flynn continues to expand his research portfolio, driving forward innovative cancer treatments to improve patient outcomes.